UniProt ID | TF7L1_HUMAN | |
---|---|---|
UniProt AC | Q9HCS4 | |
Protein Name | Transcription factor 7-like 1 | |
Gene Name | TCF7L1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 588 | |
Subcellular Localization | Nucleus. | |
Protein Description | Participates in the Wnt signaling pathway. Binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. Necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis (By similarity). Down-regulates NQO1, leading to increased mitomycin c resistance.. | |
Protein Sequence | MPQLGGGGGGGGGGSGGGGGSSAGAAGGGDDLGANDELIPFQDEGGEEQEPSSDSASAQRDLDEVKSSLVNESENQSSSSDSEAERRPQPVRDTFQKPRDYFAEVRRPQDSAFFKGPPYPGYPFLMIPDLSSPYLSNGPLSPGGARTYLQMKWPLLDVPSSATVKDTRSPSPAHLSNKVPVVQHPHHMHPLTPLITYSNDHFSPGSPPTHLSPEIDPKTGIPRPPHPSELSPYYPLSPGAVGQIPHPLGWLVPQQGQPMYSLPPGGFRHPYPALAMNASMSSLVSSRFSPHMVAPAHPGLPTSGIPHPAIVSPIVKQEPAPPSLSPAVSVKSPVTVKKEEEKKPHVKKPLNAFMLYMKEMRAKVVAECTLKESAAINQILGRKWHNLSREEQAKYYELARKERQLHSQLYPTWSARDNYGKKKKRKREKQLSQTQSQQQVQEAEGALASKSKKPCVQYLPPEKPCDSPASSHGSMLDSPATPSAALASPAAPAATHSEQAQPLSLTTKPETRAQLALHSAAFLSAKAAASSSGQMGSQPPLLSRPLPLGSMPTALLASPPSFPATLHAHQALPVLQAQPLSLVTKSAH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | GGGGGGGSGGGGGSS CCCCCCCCCCCCCCC | 37.22 | 28985074 | |
77 | Phosphorylation | VNESENQSSSSDSEA CCCCCCCCCCCCHHH | 43.71 | 29888752 | |
78 | Phosphorylation | NESENQSSSSDSEAE CCCCCCCCCCCHHHH | 24.89 | 29888752 | |
79 | Phosphorylation | ESENQSSSSDSEAER CCCCCCCCCCHHHHH | 43.33 | 29888752 | |
80 | Phosphorylation | SENQSSSSDSEAERR CCCCCCCCCHHHHHC | 47.29 | 28985074 | |
82 | Phosphorylation | NQSSSSDSEAERRPQ CCCCCCCHHHHHCCC | 40.43 | 29888752 | |
131 | Phosphorylation | FLMIPDLSSPYLSNG EEECCCCCCCCCCCC | 36.33 | 27251275 | |
132 | Phosphorylation | LMIPDLSSPYLSNGP EECCCCCCCCCCCCC | 25.51 | 27251275 | |
136 | Phosphorylation | DLSSPYLSNGPLSPG CCCCCCCCCCCCCCC | 33.62 | 28348404 | |
141 | Phosphorylation | YLSNGPLSPGGARTY CCCCCCCCCCCHHHH | 25.32 | 28348404 | |
169 | Phosphorylation | ATVKDTRSPSPAHLS CCCCCCCCCCHHHHC | 31.64 | 27794612 | |
171 | Phosphorylation | VKDTRSPSPAHLSNK CCCCCCCCHHHHCCC | 35.65 | 24961811 | |
176 | Phosphorylation | SPSPAHLSNKVPVVQ CCCHHHHCCCCCCCC | 25.41 | 27251275 | |
285 | Phosphorylation | ASMSSLVSSRFSPHM CCHHHHHHHCCCCCC | 22.53 | 24719451 | |
289 | Phosphorylation | SLVSSRFSPHMVAPA HHHHHCCCCCCCCCC | 16.88 | 28348404 | |
312 | Phosphorylation | IPHPAIVSPIVKQEP CCCCCEECCCCCCCC | 11.64 | 24719451 | |
323 | Phosphorylation | KQEPAPPSLSPAVSV CCCCCCCCCCCCEEE | 40.18 | 28348404 | |
325 | Phosphorylation | EPAPPSLSPAVSVKS CCCCCCCCCCEEECC | 18.36 | 28985074 | |
329 | Phosphorylation | PSLSPAVSVKSPVTV CCCCCCEEECCCCCC | 26.40 | 28348404 | |
332 | Phosphorylation | SPAVSVKSPVTVKKE CCCEEECCCCCCCCH | 23.58 | 21406692 | |
348 | Ubiquitination | EKKPHVKKPLNAFML HCCCCCCCHHHHHHH | 54.36 | 22505724 | |
349 | Ubiquitination | KKPHVKKPLNAFMLY CCCCCCCHHHHHHHH | 25.73 | 22505724 | |
358 | Ubiquitination | NAFMLYMKEMRAKVV HHHHHHHHHHHHHHH | 34.50 | - | |
358 | Acetylation | NAFMLYMKEMRAKVV HHHHHHHHHHHHHHH | 34.50 | - | |
363 | Acetylation | YMKEMRAKVVAECTL HHHHHHHHHHHHCCC | 27.20 | - | |
373 | Phosphorylation | AECTLKESAAINQIL HHCCCCHHHHHHHHH | 22.78 | 22210691 | |
394 | Ubiquitination | LSREEQAKYYELARK CCHHHHHHHHHHHHH | 48.32 | 24816145 | |
395 | Phosphorylation | SREEQAKYYELARKE CHHHHHHHHHHHHHH | 12.75 | - | |
395 | Ubiquitination | SREEQAKYYELARKE CHHHHHHHHHHHHHH | 12.75 | 24816145 | |
396 | Phosphorylation | REEQAKYYELARKER HHHHHHHHHHHHHHH | 12.08 | - | |
421 | Ubiquitination | SARDNYGKKKKRKRE HHHCCCCHHHHHHHH | 51.57 | 24816145 | |
422 | Ubiquitination | ARDNYGKKKKRKREK HHCCCCHHHHHHHHH | 60.20 | 24816145 | |
449 | Phosphorylation | EAEGALASKSKKPCV HHHHHHHHCCCCCCC | 38.01 | - | |
488 | Phosphorylation | TPSAALASPAAPAAT CHHHHHHCCCCCCCC | 18.87 | - | |
495 | Phosphorylation | SPAAPAATHSEQAQP CCCCCCCCCCCCCCC | 28.21 | - | |
511 | Phosphorylation | SLTTKPETRAQLALH CCCCCHHHHHHHHHH | 39.57 | - | |
519 | Phosphorylation | RAQLALHSAAFLSAK HHHHHHHHHHHHHHH | 23.34 | - | |
524 | Phosphorylation | LHSAAFLSAKAAASS HHHHHHHHHHHHHHC | 22.67 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TF7L1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TF7L1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DAZP2_HUMAN | DAZAP2 | physical | 19304756 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...